Multiple Law Firms Seek Lead Role in New Phreesia Securities Suit

Overview

• On Monday, June 22, several plaintiff firms publicly solicited Phreesia investors to join a securities class action and to seek appointment as lead plaintiff.
• The complaint covers purchases from May 8, 2025 through March 30, 2026 and alleges Phreesia made false or misleading statements about its long‑term growth outlook.
• Central allegations say the company overstated confidence in fiscal 2027 revenue guidance and mischaracterized pharmaceutical marketing commitments as a reliable growth driver for its Network Solutions unit.
• Investors have until July 13, 2026 to move for lead‑plaintiff status, and no lead plaintiff has been appointed and the class is not certified at this early procedural stage.
• Which investor group wins lead status could affect counsel choice, the speed of discovery, settlement dynamics, and whether plaintiffs can later prove falsity and loss causation to secure recoveries.